Kliničke studije za Lupus u državi Kalifornija
27 studija za Lupus traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- Santa Monica8 studija
- Los Angeles8 studija
- San Diego7 studija
- Buena Park7 studija
- Fullerton5 studija
- San Francisco4 studija
- San Leandro3 studija
- Upland3 studija
- Sacramento3 studija
Službeni tekst studije (engleski)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50737, Beverly Hills
- Sl0044 50775, Beverly Hills
- Sl0044 50257, La Jolla
- i još 6
U tijeku regrutacijaFaza 3
Od 16 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
U tijeku regrutacijaFaza 2
Od 18 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Wallace & Lee Center, Beverly Hills
- Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma
- University of California San Diego, San Diego
- i još 3
U tijeku regrutacijaFaza 2
Od 18 do 74 godina · Oba spola · Ažurirano 1. lis 2026. · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Providence Medical Center, Burbank
- Advanced Medical Research, La Palma
U tijeku regrutacijaFaza 3
Od 12 do 100 godina · Oba spola · Ažurirano 1. lis 2026. · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Los Angeles
U tijeku regrutacijaFaza 3
Od 5 do 17 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT05835310A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Fontana
- Research Site, La Jolla
- Research Site, La Palma
- i još 3
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- David S Hallegua MD A Professional Corporation, Beverly Hills
- Providence Medical Foundation, Fullerton
- Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis, Hemet
- i još 5
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Solace Research /ID# 279155, Tustin
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 25. ruj 2026. · NCT07607964Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 23. ruj 2026. · NCT03816345Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Fullerton
U tijeku regrutacijaFaza 1
Od 18 do 65 godina · Oba spola · Ažurirano 18. ruj 2026. · NCT07201558A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 15. ruj 2026. · NCT06916806Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
U tijeku regrutacijaFaza 1
Od 18 do 60 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Inland Rheumatology Clinical Trials, Inc., Upland
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- i još 2
U tijeku regrutacijaFaza 2
Od 12 do 70 godina · Oba spola · Ažurirano 14. ruj 2026. · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Dermatology Research Associates - 300204025, Los Angeles
- Cohen Medical Centers, Thousand Oaks
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 11. ruj 2026. · NCT07332481A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
U tijeku regrutacijaFaza 1
Od 18 do 74 godina · Oba spola · Ažurirano 10. ruj 2026. · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0054, La Jolla
- Local Institution - 0001, La Palma
- Local Institution - 0071, Los Angeles
- i još 1
U tijeku regrutacijaOpažajna studija
Od 16 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT07175285FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
U tijeku regrutacijaFaza 1/2
Od 18 do 70 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
U tijeku regrutacijaFaza 1
Od 18 do 70 godina · Oba spola · Ažurirano 28. kol 2026. · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
U tijeku regrutacijaFaza 1/2
Od 18 do 65 godina · Oba spola · Ažurirano 26. kol 2026. · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- University of California, Los Angeles, Los Angeles
- University of California: San Diego, San Diego
U tijeku regrutacijaFaza 3
Od 55 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Beverly Hills
U tijeku regrutacijaFaza 2
Od 18 do 80 godina · Oba spola · Ažurirano 27. srp 2026. · NCT07260877Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
- Carewell Arthritis Center, Apple Valley
- Attune Health Research Inc, Beverly Hills
- Covina Arthritis Clinic, Covina
- i još 4
U tijeku regrutacijaFaza 1
Od 18 do 75 godina · Oba spola · Ažurirano 20. srp 2026. · NCT07237659A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US06-0, La Palma
U tijeku regrutacijaFaza 1/2Zdravi dobrovoljci dobrodošli
Od 18 do 70 godina · Oba spola · Ažurirano 2. lip 2026. · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- i još 2
U tijeku regrutacijaFaza 1
Od 12 do 70 godina · Oba spola · Ažurirano 22. svi 2026. · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
U tijeku regrutacijaOpažajna studija
Od 18 do 110 godina · Oba spola · Ažurirano 15. tra 2026. · NCT05934149Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.